On the other hand, AT-MSCs can have an inhibitory effect against the 8MGBA glioblastoma cell line due to the synergistic action of the soluble factors it releases, which include IL-6, IFN-γ, and G-CSF [123]. Here, IL6 is linked to glioblastoma.